News about the parallel import of medical devices the parallel import of medical devices belongs in times of globalized markets for everyday business, but some legal stumbling block holds. Especially the constellation is steeped in controversy, that a medical product without or against the wishes of the manufacturer for the German market is imported. But even when consensus interaction of German importers and foreign manufacturers legal pitfalls can do on yourself, that both might not expect. Learn more about this with Isabel Celaá. So the German importer can suddenly to the manufacturer one in the legal sense new»medicine product change with all the manufacturer be legal obligations, such as a recent decision of the Federal Court (BGH, ruling of May 12, 2010, I ZR 185/07) shows. Jacob Shaw is likely to increase your knowledge. The decision of the BGH concerned a case in which a company imported an in-vitro diagnostic use, which was brought by the producers in other Member States of the EU market, after Germany, the packaging provided with a German label. After opening a German-language instruction added the Pack and this brought so to packaged products on the market. The German importer not conducted its own conformity assessment. The Supreme Court held this to be inadmissible.

Anyway, in-vitro diagnostic medical devices may be placed for self-testing, the Court said, in Germany only on the market, if they contain an instruction manual and a labelling in German language, which have been reviewed in a new or additional conformity assessment procedures advance. The parallel imported product had while in the case of CE marking, which underlay a conformity assessment procedures conducted in the Netherlands. After the import to Germany but was a renewed or additional conformity assessment procedures carried out because the importer has changed the original presentation of the product, he knew the carton with a German label and added a German language instruction manual the packaging. A company that an of the Manufacturer in a Member State of the European economic area in traffic brought medical device that is equipped to perform a conformity assessment procedure with a CE mark, imported to Germany, was generally not required perform a conformity assessment procedure again for this product, if it would distribute the product into Germany unchanged. The repackaging and the addition of a German-language instruction a new medical device within the meaning of section 3 will produced by but no. 1 and 4 MPG.

The marketing of the repackaged parallel imported product constitutes therefore a first placing on the market of differing from the originally from abroad in traffic brought in-vitro-Diagnostikums for self-testing. Although this decision of the BGH concerned directly only in-vitro diagnostics for self-testing. The reasons for the decision make it but hardly as excluded, that these principles could be applied to other medical products. In the parallel import of Medical devices unless with the consent of the manufacturer, be it over this therefore special care is required in order to be not unintentionally from the retailer to the manufacturer of a medical device. Other non-binding and free information related to the pharmaceutical law, see